| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Strategy And Innovation
1 company
Parkinson Paul is an EVP Strategy And Innovation at MYGN. Recent filings cover 0 purchases and 1 sale. Those positions are worth an estimated $285K at current prices.
Parkinson Paul's largest disclosed position is in MYGN as EVP Strategy And Innovation, worth about $285K. The recent filings there lean toward selling, a net 11,824 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2021 | MYGN Myriad Genetics Inc | EVP Strategy And Innovation | Sell | 11,824 | $25.00 | $295,600.00 | -13.3% |